Cellectar Biosciences Inc

General ticker "CLRB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $38.7M

Cellectar Biosciences Inc does not follow the US Stock Market performance with the rate: -30.3%.

Estimated limits based on current volatility of 1.6%: low 0.22$, high 0.26$

Factors to consider:

  • Current price 85.5% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.91$, 5.65$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.80$, 5.15$]

Financial Metrics affecting the CLRB estimates:

  • Negative: Non-GAAP EPS, $ of -2.86 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -51.12 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term CLRB quotes

Long-term CLRB plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $24.13MM $28.81MM $38.96MM
Operating Income $-24.13MM $-28.81MM $-38.96MM
Non-Operating Income $0.01MM $0.15MM $0.92MM
R&D Expense $17.59MM $19.22MM $27.27MM
Income(Loss) $-24.12MM $-28.66MM $-38.04MM
Taxes $0.00MM $-0.06MM $-0.06MM
Profit(Loss) $-24.12MM $-28.60MM $-37.98MM
Stockholders Equity $33.05MM $15.51MM $-15.16MM
Assets $37.20MM $21.59MM $12.08MM
Operating Cash Flow $-22.57MM $-25.22MM $-32.38MM
Capital expenditure $0.14MM $0.23MM $0.86MM
Investing Cash Flow $-0.14MM $-0.23MM $-0.86MM
Financing Cash Flow $1.25MM $9.61MM $22.94MM
Earnings Per Share* $-4.32 $-4.05 $-3.11

* EPS are Split Adjusted, recent splits may be reflected with a delay.